An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials

被引：0
|
作者：
Rongji Mu
Zongliang Hu
Guoying Xu
Haitao Pan
机构：
[1] Shanghai Jiao Tong University School of Medicine,Clinical Research Center
[2] Shenzhen University,College of Mathematics and Statistics
[3] Jiangsu Hengrui Medicine Co.,Department of Biostatistics
[4] Ltd,undefined
[5] St. Jude Children’s Research Hospital,undefined
来源：
BMC Medical Research Methodology | / 21卷
关键词：
Bayesian adaptive design; Phase I dose-finding trial; Shrinkage boundaries; Maximum tolerated dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
    Mu, Rongji
    Hu, Zongliang
    Xu, Guoying
    Pan, Haitao
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
  • [2] A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
    Li, Zhaohang
    Xu, Ze
    Zhang, Aijun
    Qi, Guanpeng
    Li, Zuojing
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [3] A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
    Zhaohang Li
    Ze Xu
    Aijun Zhang
    Guanpeng Qi
    Zuojing Li
    [J]. BMC Medical Research Methodology, 23
  • [4] A phase I dose-finding design with incorporation of historical information and adaptive shrinking boundaries
    Li, Chen
    Pan, Haitao
    [J]. PLOS ONE, 2020, 15 (08):
  • [5] An adaptive model switching approach for phase I dose-finding trials
    Daimon, Takashi
    Zohar, Sarah
    [J]. PHARMACEUTICAL STATISTICS, 2013, 12 (04) : 225 - 232
  • [6] Adaptive Design of Personalized Dose-Finding Clinical Trials
    Delshad, Saeid
    Khademi, Amin
    [J]. SERVICE SCIENCE, 2022, 14 (04) : 273 - 291
  • [7] Adaptive Bayesian Design for Phase I Dose-Finding Trials Using a Joint Model of Response and Toxicity
    Wang, Meihua
    Day, Roger
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (01) : 125 - 144
  • [8] Bayesian hybrid dose-finding design in phase I oncology clinical trials
    Yuan, Ying
    Yin, Guosheng
    [J]. STATISTICS IN MEDICINE, 2011, 30 (17) : 2098 - 2108
  • [9] Design Issues in Dose-Finding Phase I Trials for Combinations of Two Agents
    Fan, Shenghua Kelly
    Venook, Alan P.
    Lu, Ying
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (03) : 509 - 523
  • [10] A robust Bayesian dose-finding design for phase I/II clinical trials
    Liu, Suyu
    Johnson, Valen E.
    [J]. BIOSTATISTICS, 2016, 17 (02) : 249 - 263
12345